Up­dat­ed: MD An­der­son-al­lied in­vest­ment firm tar­gets $250M for sec­ond can­cer biotech fund

Head­ed in­to the biggest on­col­o­gy re­search and de­vel­op­ment con­fab of the year, an in­vest­ment firm part­nered with one of the na­tion’s pre­mier can­cer in­sti­tu­tions is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER